Apeiron Therapeutics is strategically based in Shanghai and in the San Francisco Bay Area, with significant collaborations in the UK enabling us to tap into technologies and talent from all three continents.
Our team and partners bring together deep expertise in applied artificial intelligence (AI) and drug discovery to enable efficient and scalable discovery and development of novel drugs. We apply AI at every stage of the research process from target identification to drug discovery and biomarker elucidation.
Employing cutting-edge science and technology to deliver breakthrough therapeutics.
Artificial Intelligence to revolutionize new drug discovery process.
Science, innovation and patient centric.
With a global footprint spanning Asia, Europe and the United States, Apeiron Therapeutics is working with its partners to accelerate the R&D process to rapidly and efficiently deliver breakthrough therapies to patients across the globe.
The Schodinger Building The Oxford Science Park, Oxford OX4 4Ge, United Kingdom.
HongKong 22 Pottinger Street,Central
Bay Area Office:
101 Mississippi StreetSan Francisco, CA, 94107United States
West zone,1st Floor, Block C, No.1976 Middle Gaoke Road, Pudong New District, Shanghai